Epigenic Therapeutics Information
Contact top employees from
Epigenic Therapeutics
Summary
Epigenic Therapeutics is a frontier biotechnology company dedicated to developing next generation gene editing therapy utilizing regulation of epigenetic genome for a variety of diseases. Founded in 2...Show more
Organization Website | epigenictx.com |
Social Links |  |
Industries | |
Headquarters Location | 上海浦东新区上海自贸壹号生命科技产业园(一期)4-15F6F, CN |
Employees Size | 100-200 employees |
Specialties | gene therapy, epigenetic editing |
Founded | 2021 |
Competitors
Founded | Type | Employees | Revenue | Funding | |
|---|---|---|---|---|---|
| 2018 | Privately Held | 1 - 25 | 6M | $109.5M | |
| 2018 | Privately Held | 25 - 100 | < 1M | $74M | |
| 2019 | - | 10-50 | - | $- | |
| 2020 | - | 1-10 | - | $- |
Employees Turnover 4 quarter 2025
Length of Employment
Employee tenure at Epigenic Therapeutics shows a diverse range of experience levels:
50% for 1–2 years50% for 3–4 yearsContact top employees from
Epigenic Therapeutics
Xinyu Huang
COO & Head of CMC
Grace HUANG
Platform head
Qianchao Wu
BD Head
minghao bao
Head of HR & Government Affairs, Sr. Director
Jingwen Guan
Senior Molecular Biology Scientist
Similar Companies
FAQ
Epigenic Therapeutics operates in the Biotech industries. More details can be found on the official website: epigenictx.com.
The headquarters of Epigenic Therapeutics are located in 上海, China.
Epigenic Therapeutics currently employs 100-200 people.
Well-known competitors of Epigenic Therapeutics include Aro Biotherapeutics, Nutcracker Therapeutics, OCEAN BIOMEDICAL and Prolocor.
Data Privacy
GDPR COMPLIANT
SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.
CCPA COMPLIANT
SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.
